× Current Issue Archive Submit Article
Conflicts of Interest Copyright and Access Open access policy Editorial Policies Peer Review Policy Privacy Statement Publishing Ethics
Editor in chief Associate Editors Advisory Board International Editors
Contact Us About Us Aim & Scope Abstracting And Indexing Author Guidelines Join As Editor
Views: 822 Downloads: 113

Clinical pharmacist participation improved the cost-effectiveness of antibiotic treatment in a pediatric intensive care unit


, ,

Abstract

Based on a survey conducted by the Antibiotics Control Program of the Department of Pediatrics, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia, the use of antibiotics and evidence of antibiotic resistance in the Pediatric Intensive Care Unit (PICU) was found to be worse than average. This study aimed to evaluate the cost-effectiveness of the participation of clinical pharmacists in the PICU. A non-parallel experimental study cost-effectiveness. The study population consisted of two groups: those who received a recommendation from a clinical pharmacist (R group, n=51) and those who did not (NR group, n=42). The direct medical costs measured were the cost of the anti-bacterial agent, hospital administration, physician visits, and microbial laboratory tests. ACER and ICER were calculated using the proportion of patients with length of stay (LOS) of < = 3 days. Within the three months of the study, 120 recommendations were made. There were no significant differences in characteristics between the two groups. The effectivity of the R group (35.83%) was significantly higher than the NR group (30.26%) (p < 0.05), and the cost was also significantly lower in the R group (p < 0.05). It was also cost-saving, as shown by the ICER of the R group relative to the NR group minus IDR 395,095/effectivity-gained. Sensitivity analysis confirmed the robustness of these results. The participation of clinical pharmacists in prescription review and giving recommendations on antibiotic therapy can reduce costs and LOS of pediatric patients in PICU.


How to cite this article:
Vancouver
Sauriasari R, Rizkyani NA, Tambunan T. Clinical pharmacist participation improved the cost-effectiveness of antibiotic treatment in a pediatric intensive care unit. J Adv Pharm Educ Res. 2023;13(4):93-8. https://doi.org/10.51847/8k1tg176ra
APA
Sauriasari, R., Rizkyani, N. A., & Tambunan, T. (2023). Clinical pharmacist participation improved the cost-effectiveness of antibiotic treatment in a pediatric intensive care unit. Journal of Advanced Pharmacy Education and Research, 13(4), 93-98. https://doi.org/10.51847/8k1tg176ra
Citation Formats:


Contact Meral


Meral Publications
www.meralpublisher.com

Davutpasa / Zeytinburnu 34087
Istanbul
Turkey

Email: [email protected]
Tell: +905344998991